Electromed (NYSE:ELMD) Coverage Initiated by Analysts at Roth Capital

Roth Capital started coverage on shares of Electromed (NYSE:ELMD - Free Report) in a research note issued to investors on Tuesday morning, MarketBeat.com reports. The firm issued a buy rating and a $29.00 price target on the stock. Roth Capital also issued estimates for Electromed's Q4 2025 earnings at $0.22 EPS, FY2025 earnings at $0.81 EPS, Q1 2026 earnings at $0.22 EPS, Q2 2026 earnings at $0.31 EPS, Q3 2026 earnings at $0.21 EPS, Q4 2026 earnings at $0.26 EPS, FY2026 earnings at $1.00 EPS and FY2027 earnings at $1.15 EPS.

Several other research firms have also recently commented on ELMD. Wall Street Zen cut shares of Electromed from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 8th. B. Riley upgraded shares of Electromed to a "strong-buy" rating in a research note on Thursday, May 15th.

Electromed Price Performance

Shares of ELMD stock traded down $0.03 during mid-day trading on Tuesday, hitting $18.62. The stock had a trading volume of 7,789 shares, compared to its average volume of 87,160. Electromed has a fifty-two week low of $13.74 and a fifty-two week high of $35.56. The firm has a market cap of $156.11 million, a PE ratio of 24.82 and a beta of 0.41. The company's 50-day simple moving average is $20.27 and its 200-day simple moving average is $24.58.

Institutional Trading of Electromed

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Squarepoint Ops LLC lifted its stake in shares of Electromed by 7.8% in the fourth quarter. Squarepoint Ops LLC now owns 11,366 shares of the company's stock valued at $336,000 after purchasing an additional 823 shares during the period. Aristides Capital LLC increased its holdings in Electromed by 4.7% during the 4th quarter. Aristides Capital LLC now owns 26,076 shares of the company's stock valued at $771,000 after acquiring an additional 1,159 shares in the last quarter. Russell Investments Group Ltd. purchased a new position in Electromed during the 4th quarter valued at about $37,000. Quantbot Technologies LP increased its holdings in Electromed by 57.7% during the 1st quarter. Quantbot Technologies LP now owns 5,301 shares of the company's stock valued at $126,000 after acquiring an additional 1,939 shares in the last quarter. Finally, State of Wyoming purchased a new position in Electromed during the 1st quarter valued at about $48,000. Institutional investors and hedge funds own 40.82% of the company's stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.